Want to see KR:137310 full AI Analyst Report?
SD Biosensor, Inc. (137310) Financial Statements
SD Biosensor, Inc. Financial Overview
SD Biosensor, Inc.'s market cap is currently $752.05B. The company's EPS TTM is $-6063.66; its P/E ratio is -1.04; and it has a dividend yield of 3.15%. SD Biosensor, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 710.58B | $ 694.57B | $ 655.68B | $ 2.93T | $ 2.93T |
| Gross Profit | $ 225.89B | $ 339.39B | $ 122.45B | $ 1.39T | $ 1.57T |
| Operating Income | $ -82.86B | $ -54.06B | $ -248.08B | $ 1.15T | $ 1.36T |
| EBITDA | $ 51.41B | $ -5.37B | $ -250.86B | $ 1.28T | $ 1.41T |
| Net Income | $ -521.41B | $ -98.41B | $ -467.71B | $ 911.36B | $ 1.09T |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 770.49B | $ 467.75B | $ 557.72B | $ 2.07T | $ 1.90T |
| Total Assets | $ 3.24T | $ 3.89T | $ 3.79T | $ 3.26T | $ 3.01T |
| Total Debt | $ 669.03B | $ 606.52B | $ 603.95B | $ 24.79B | $ 24.97B |
| Net Debt | $ 302.25B | $ 429.09B | $ 121.57B | $ -1.85T | $ -856.62B |
| Total Liabilities | $ 909.44B | $ 956.18B | $ 957.28B | $ 315.14B | $ 801.72B |
| Stockholders' Equity | $ 2.32T | $ 2.92T | $ 2.82T | $ 2.94T | $ 2.19T |
| Cash Flow | |||||
| Free Cash Flow | $ 300.43B | $ 75.62B | $ -387.01B | $ 589.78B | $ 1.14T |
| Operating Cash Flow | $ 357.52B | $ 156.53B | $ -242.32B | $ 890.23B | $ 1.23T |
| Investing Cash Flow | $ -139.94B | $ -338.93B | $ -1.91T | $ 358.52B | $ -957.73B |
| Financing Cash Flow | $ -27.58B | $ -146.27B | $ 769.76B | $ -225.74B | $ 351.26B |
Currency in KRW
